Pineapple, Papaya & Fig Enzymes Wipe Out Eye Floaters in 70% of People – Game-Changing Study Shocks Doctors!
A clinical study published in the Journal of Clinical Medicine (2022) explored the potential of a supplement made from mixed fruit enzymes to alleviate bothersome eye floaters, also known as symptomatic vitreous opacities.In this rigorous double-blind, placebo-controlled trial, researchers enrolled 224 patients between the ages of 30 and 60 who were experiencing noticeable floaters in one eye.
Participants were divided based on the cause of their floaters—either spontaneous (due to natural vitreous degeneration) or secondary to vitreous hemorrhage (bleeding in the eye’s gel-like interior).The treatment involved daily oral capsules containing a precise blend of natural enzymes: 190 mg bromelain (extracted from pineapple stems), 95 mg papain (from papaya), and 95 mg ficin (from figs). These were administered in varying doses—1, 2, or 3 capsules per day—over a full three-month period. For comparison, the placebo group received vitamin C capsules instead.To objectively track progress, the team used advanced imaging techniques including retinal photography, ocular ultrasound, and optical coherence tomography (OCT) to count and assess floaters at the start of the study and then monthly throughout the trial. They also evaluated patients’ subjective symptoms, overall satisfaction with the treatment, and, where relevant, changes in visual acuity (measured in LogMAR units).The findings revealed a clear dose-dependent improvement.
Among those with spontaneous floaters:Taking one capsule daily resulted in about 55% of floaters disappearing. Two capsules per day increased the disappearance rate to 62.5%. The highest dose of three capsules daily achieved up to 70% resolution of the opacities (with statistically significant differences, p < 0.001). In the subgroup dealing with floaters triggered by vitreous hemorrhage, results were more variable at lower doses (18% and 25% disappearance with one or two capsules), but the maximum dose of three capsules produced a 56% disappearance rate (p < 0.001). Notably, these patients also experienced a meaningful boost in corrected distance visual acuity, improving from an average of 0.63 LogMAR (poorer vision) to 0.19 LogMAR (much clearer vision) by the end of the study (p = 0.008).The researchers proposed that the proteolytic (protein-breaking) action of these enzymes likely helps degrade abnormal collagen aggregates, persistent blood clots, and other debris trapped in the vitreous humor.
Additionally, the strong antioxidant properties of the enzyme mixture—demonstrated in lab tests to outperform vitamin C—may combat oxidative stress, further supporting eye tissue health and reducing floater formation.Overall, the supplement was well-tolerated with high patient satisfaction reported and no serious side effects noted. This approach represents a promising non-invasive, pharmacological option for managing vitreous floaters, particularly as an alternative to more invasive treatments like laser vitreolysis or vitrectomy surgery. While encouraging, larger follow-up studies are still needed to confirm long-term safety and efficacy across broader populations.
